360 related articles for article (PubMed ID: 28431278)
1. Intranasal oxytocin does not modulate jumping to conclusions in schizophrenia: Potential interactions with caudate volume and baseline social functioning.
Caravaggio F; Gerretsen P; Mar W; Chung JK; Plitman E; Nakajima S; Kim J; Iwata Y; Patel R; Chakravarty MM; Remington G; Graff-Guerrero A; Menon M
Psychoneuroendocrinology; 2017 Jul; 81():80-87. PubMed ID: 28431278
[TBL] [Abstract][Full Text] [Related]
2. Unstable Belief Formation and Slowed Decision-making: Evidence That the Jumping-to-Conclusions Bias in Schizophrenia Is Not Linked to Impulsive Decision-making.
Strube W; Cimpianu CL; Ulbrich M; Öztürk ÖF; Schneider-Axmann T; Falkai P; Marshall L; Bestmann S; Hasan A
Schizophr Bull; 2022 Mar; 48(2):347-358. PubMed ID: 34554260
[TBL] [Abstract][Full Text] [Related]
3. A single dose of oxytocin nasal spray improves higher-order social cognition in schizophrenia.
Guastella AJ; Ward PB; Hickie IB; Shahrestani S; Hodge MA; Scott EM; Langdon R
Schizophr Res; 2015 Nov; 168(3):628-33. PubMed ID: 26150070
[TBL] [Abstract][Full Text] [Related]
4. Effects of single dose intranasal oxytocin on social cognition in schizophrenia.
Davis MC; Lee J; Horan WP; Clarke AD; McGee MR; Green MF; Marder SR
Schizophr Res; 2013 Jul; 147(2-3):393-7. PubMed ID: 23676253
[TBL] [Abstract][Full Text] [Related]
5. Effects of Oxytocin on Neural Response to Facial Expressions in Patients with Schizophrenia.
Shin NY; Park HY; Jung WH; Park JW; Yun JY; Jang JH; Kim SN; Han HJ; Kim SY; Kang DH; Kwon JS
Neuropsychopharmacology; 2015 Jul; 40(8):1919-27. PubMed ID: 25666311
[TBL] [Abstract][Full Text] [Related]
6. A pilot six-week randomized controlled trial of oxytocin on social cognition and social skills in schizophrenia.
Gibson CM; Penn DL; Smedley KL; Leserman J; Elliott T; Pedersen CA
Schizophr Res; 2014 Jul; 156(2-3):261-5. PubMed ID: 24799299
[TBL] [Abstract][Full Text] [Related]
7. A 12-week randomized controlled trial of twice-daily intranasal oxytocin for social cognitive deficits in people with schizophrenia.
Jarskog LF; Pedersen CA; Johnson JL; Hamer RM; Rau SW; Elliott T; Penn DL
Schizophr Res; 2017 Jul; 185():88-95. PubMed ID: 28094169
[TBL] [Abstract][Full Text] [Related]
8. Dorsal striatal volumes in never-treated patients with first-episode schizophrenia before and during acute treatment.
Emsley R; Asmal L; du Plessis S; Chiliza B; Kidd M; Carr J; Vink M
Schizophr Res; 2015 Dec; 169(1-3):89-94. PubMed ID: 26441006
[TBL] [Abstract][Full Text] [Related]
9. Effects of intranasal oxytocin on neural processing within a socially relevant neural circuit.
Singh F; Nunag J; Muldoon G; Cadenhead KS; Pineda JA; Feifel D
Eur Neuropsychopharmacol; 2016 Mar; 26(3):626-30. PubMed ID: 26727038
[TBL] [Abstract][Full Text] [Related]
10. Oxytocin administration enhances controlled social cognition in patients with schizophrenia.
Woolley JD; Chuang B; Lam O; Lai W; O'Donovan A; Rankin KP; Mathalon DH; Vinogradov S
Psychoneuroendocrinology; 2014 Sep; 47():116-25. PubMed ID: 25001961
[TBL] [Abstract][Full Text] [Related]
11. Prolonged rather than hasty decision-making in schizophrenia using the box task. Must we rethink the jumping to conclusions account of paranoia?
Moritz S; Scheunemann J; Lüdtke T; Westermann S; Pfuhl G; Balzan RP; Andreou C
Schizophr Res; 2020 Aug; 222():202-208. PubMed ID: 32507550
[TBL] [Abstract][Full Text] [Related]
12. Oxytocin to modulate emotional processing in schizophrenia: A randomized, double-blind, cross-over clinical trial.
Brambilla M; Cotelli M; Manenti R; Dagani J; Sisti D; Rocchi M; Balestrieri M; Pini S; Raimondi S; Saviotti FM; Scocco P; de Girolamo G
Eur Neuropsychopharmacol; 2016 Oct; 26(10):1619-28. PubMed ID: 27527256
[TBL] [Abstract][Full Text] [Related]
13. Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: results from a randomized double blind placebo controlled pilot study.
Lee MR; Wehring HJ; McMahon RP; Linthicum J; Cascella N; Liu F; Bellack A; Buchanan RW; Strauss GP; Contoreggi C; Kelly DL
Schizophr Res; 2013 Apr; 145(1-3):110-5. PubMed ID: 23415472
[TBL] [Abstract][Full Text] [Related]
14. Mitigation of sociocommunicational deficits of autism through oxytocin-induced recovery of medial prefrontal activity: a randomized trial.
Watanabe T; Abe O; Kuwabara H; Yahata N; Takano Y; Iwashiro N; Natsubori T; Aoki Y; Takao H; Kawakubo Y; Kamio Y; Kato N; Miyashita Y; Kasai K; Yamasue H
JAMA Psychiatry; 2014 Feb; 71(2):166-75. PubMed ID: 24352377
[TBL] [Abstract][Full Text] [Related]
15. Effect of Intranasal Oxytocin on Resting-state Effective Connectivity in Schizophrenia.
Korann V; Jacob A; Lu B; Devi P; Thonse U; Nagendra B; Maria Chacko D; Dey A; Padmanabha A; Shivakumar V; Dawn Bharath R; Kumar V; Varambally S; Venkatasubramanian G; Deshpande G; Rao NP
Schizophr Bull; 2022 Sep; 48(5):1115-1124. PubMed ID: 35759349
[TBL] [Abstract][Full Text] [Related]
16. Effects of Oxytocin on Emotion Recognition in Schizophrenia: A Randomized Double-Blind Pilot Study.
Andari E; Massa NM; Fargotstein MD; Taylor NB; Halverson DM; Owens AV; Currin DL; Bhattacharya A; Gitman D; Cuthbert BC; Young LJ; Duncan EJ
J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):103-113. PubMed ID: 33587397
[TBL] [Abstract][Full Text] [Related]
17. Neural modulation of social reinforcement learning by intranasal oxytocin in male adults with high-functioning autism spectrum disorder: a randomized trial.
Kruppa JA; Gossen A; Oberwelland Weiß E; Kohls G; Großheinrich N; Cholemkery H; Freitag CM; Karges W; Wölfle E; Sinzig J; Fink GR; Herpertz-Dahlmann B; Konrad K; Schulte-Rüther M
Neuropsychopharmacology; 2019 Mar; 44(4):749-756. PubMed ID: 30390065
[TBL] [Abstract][Full Text] [Related]
18. Intranasal oxytocin reduces social perception in women: Neural activation and individual variation.
Hecht EE; Robins DL; Gautam P; King TZ
Neuroimage; 2017 Feb; 147():314-329. PubMed ID: 27989775
[TBL] [Abstract][Full Text] [Related]
19. Performance on a probabilistic inference task in healthy subjects receiving ketamine compared with patients with schizophrenia.
Evans S; Almahdi B; Sultan P; Sohanpal I; Brandner B; Collier T; Shergill SS; Cregg R; Averbeck BB
J Psychopharmacol; 2012 Sep; 26(9):1211-7. PubMed ID: 22389244
[TBL] [Abstract][Full Text] [Related]
20. Glutamatergic Contribution to Probabilistic Reasoning and Jumping to Conclusions in Schizophrenia: A Double-Blind, Randomized Experimental Trial.
Strube W; Marshall L; Quattrocchi G; Little S; Cimpianu CL; Ulbrich M; Schneider-Axmann T; Falkai P; Hasan A; Bestmann S
Biol Psychiatry; 2020 Nov; 88(9):687-697. PubMed ID: 32513424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
